A new target of radiotherapy combined with immunotherapy: regulatory T cells

Radiotherapy is one important treatment for malignant tumours. It is widely believed today that radiotherapy has not only been used as a local tumour treatment method, but also can induce systemic anti-tumour responses by influencing the tumour microenvironment, but its efficacy is limited by the tu...

Full description

Bibliographic Details
Main Authors: Dongmei Song, Yun Ding
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1330099/full
_version_ 1797362411422875648
author Dongmei Song
Yun Ding
author_facet Dongmei Song
Yun Ding
author_sort Dongmei Song
collection DOAJ
description Radiotherapy is one important treatment for malignant tumours. It is widely believed today that radiotherapy has not only been used as a local tumour treatment method, but also can induce systemic anti-tumour responses by influencing the tumour microenvironment, but its efficacy is limited by the tumour immunosuppression microenvironment. With the advancement of technology, immunotherapy has entered a golden age of rapid development, gradually occupying a place in clinical tumour treatment. Regulatory T cells (Tregs) widely distributing in the tumour microenvironment play an important role in mediating tumour development. This article analyzes immunotherapy, the interaction between Tregs, tumours and radiotherapy. It briefly introduces immunotherapies targeting Tregs, aiming to provide new strategies for radiotherapy combined with Immunotherapy.
first_indexed 2024-03-08T16:07:38Z
format Article
id doaj.art-aabad67328f64ecbadd8c19f55d15b9f
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-08T16:07:38Z
publishDate 2024-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-aabad67328f64ecbadd8c19f55d15b9f2024-01-08T05:07:15ZengFrontiers Media S.A.Frontiers in Immunology1664-32242024-01-011410.3389/fimmu.2023.13300991330099A new target of radiotherapy combined with immunotherapy: regulatory T cellsDongmei SongYun DingRadiotherapy is one important treatment for malignant tumours. It is widely believed today that radiotherapy has not only been used as a local tumour treatment method, but also can induce systemic anti-tumour responses by influencing the tumour microenvironment, but its efficacy is limited by the tumour immunosuppression microenvironment. With the advancement of technology, immunotherapy has entered a golden age of rapid development, gradually occupying a place in clinical tumour treatment. Regulatory T cells (Tregs) widely distributing in the tumour microenvironment play an important role in mediating tumour development. This article analyzes immunotherapy, the interaction between Tregs, tumours and radiotherapy. It briefly introduces immunotherapies targeting Tregs, aiming to provide new strategies for radiotherapy combined with Immunotherapy.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1330099/fullradiotherapyTregsimmunotherapyradiosensitivityimmune microenvironment
spellingShingle Dongmei Song
Yun Ding
A new target of radiotherapy combined with immunotherapy: regulatory T cells
Frontiers in Immunology
radiotherapy
Tregs
immunotherapy
radiosensitivity
immune microenvironment
title A new target of radiotherapy combined with immunotherapy: regulatory T cells
title_full A new target of radiotherapy combined with immunotherapy: regulatory T cells
title_fullStr A new target of radiotherapy combined with immunotherapy: regulatory T cells
title_full_unstemmed A new target of radiotherapy combined with immunotherapy: regulatory T cells
title_short A new target of radiotherapy combined with immunotherapy: regulatory T cells
title_sort new target of radiotherapy combined with immunotherapy regulatory t cells
topic radiotherapy
Tregs
immunotherapy
radiosensitivity
immune microenvironment
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1330099/full
work_keys_str_mv AT dongmeisong anewtargetofradiotherapycombinedwithimmunotherapyregulatorytcells
AT yunding anewtargetofradiotherapycombinedwithimmunotherapyregulatorytcells
AT dongmeisong newtargetofradiotherapycombinedwithimmunotherapyregulatorytcells
AT yunding newtargetofradiotherapycombinedwithimmunotherapyregulatorytcells